Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection

Patients with end stage kidney disease receiving in-center hemodialysis (ICHD) have had high rates of SARS-CoV-2 infection. Following infection, patients receiving ICHD frequently develop circulating antibodies to SARS-CoV-2, even with asymptomatic infection. Here, we investigated the durability and...

Descripción completa

Detalles Bibliográficos
Autores principales: Clarke, Candice L., Prendecki, Maria, Dhutia, Amrita, Gan, Jaslyn, Edwards, Claire, Prout, Virginia, Lightstone, Liz, Parker, Eleanor, Marchesin, Federica, Griffith, Megan, Charif, Rawya, Pickard, Graham, Cox, Alison, McClure, Myra, Tedder, Richard, Randell, Paul, Greathead, Louise, Guckian, Mary, McAdoo, Stephen P., Kelleher, Peter, Willicombe, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Nephrology. Published by Elsevier Inc. 2021
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992297/
https://www.ncbi.nlm.nih.gov/pubmed/33774082
http://dx.doi.org/10.1016/j.kint.2021.03.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992297/
https://www.ncbi.nlm.nih.gov/pubmed/33774082
http://dx.doi.org/10.1016/j.kint.2021.03.009

Ejemplares similares